Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric D Marsh

Showing results (91-100 of 156) with videos related to

Pageof 16
Sort By:
Journal of Neurosurgery. Pediatrics|September 5, 2015
Clinical and histopathological outcomes in patients with SCN1A mutations undergoing surgery for epilepsyKaren L Skjei, Ephraim W Church, Brian N Harding, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in miceI-Ting Judy Wang, Megan Allen, Darren Goffin, et al.
Med (New York, N.Y.)|June 25, 2024
Trofinetide for the treatment of Rett syndrome: Results from the open-label extension LILAC studyAlan K Percy, Jeffrey L Neul, Timothy A Benke, et al.
Annals of Neurology|August 29, 2020
PIK3R2/Pik3r2 Activating Mutations Result in Brain Overgrowth and EEG ChangesXiuyu Shi, Youngshin Lim, Abigail K Myers, et al.
Nature Medicine|June 8, 2023
Trofinetide for the treatment of Rett syndrome: a randomized phase 3 studyJeffrey L Neul, Alan K Percy, Timothy A Benke, et al.
Med (New York, N.Y.)|July 18, 2024
Trofinetide for the treatment of Rett syndrome: Long-term safety and efficacy results of the 32-month, open-label LILAC-2 studyAlan K Percy, Jeffrey L Neul, Timothy A Benke, et al.
Pediatric Neurology|January 17, 2024
Trofinetide Treatment Demonstrates a Benefit Over Placebo for the Ability to Communicate in Rett SyndromeJeffrey L Neul, Alan K Percy, Timothy A Benke, et al.
American Journal of Medical Genetics. Part A|June 14, 2025
Medical Biases and Misconceptions Impact Diagnoses in Males With Loss of Function MECP2 VariantsTalia Thompson, Dennis Gurfinkel, Lori Silveira, et al.
Epilepsia|December 9, 2022
Spike patterns surrounding sleep and seizures localize the seizure-onset zone in focal epilepsyErin C Conrad, Andrew Y Revell, Adam S Greenblatt, et al.
Journal of Neurodevelopmental Disorders|January 25, 2025
A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndromeKathleen Campbell, Jeffrey L Neul, David N Lieberman, et al.
Pageof 16

Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
Journal of Neurosurgery. Pediatrics|September 5, 2015
Clinical and histopathological outcomes in patients with SCN1A mutations undergoing surgery for epilepsyKaren L Skjei, Ephraim W Church, Brian N Harding, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in miceI-Ting Judy Wang, Megan Allen, Darren Goffin, et al.
Med (New York, N.Y.)|June 25, 2024
Trofinetide for the treatment of Rett syndrome: Results from the open-label extension LILAC studyAlan K Percy, Jeffrey L Neul, Timothy A Benke, et al.
Annals of Neurology|August 29, 2020
PIK3R2/Pik3r2 Activating Mutations Result in Brain Overgrowth and EEG ChangesXiuyu Shi, Youngshin Lim, Abigail K Myers, et al.
Nature Medicine|June 8, 2023
Trofinetide for the treatment of Rett syndrome: a randomized phase 3 studyJeffrey L Neul, Alan K Percy, Timothy A Benke, et al.
Med (New York, N.Y.)|July 18, 2024
Trofinetide for the treatment of Rett syndrome: Long-term safety and efficacy results of the 32-month, open-label LILAC-2 studyAlan K Percy, Jeffrey L Neul, Timothy A Benke, et al.
Pediatric Neurology|January 17, 2024
Trofinetide Treatment Demonstrates a Benefit Over Placebo for the Ability to Communicate in Rett SyndromeJeffrey L Neul, Alan K Percy, Timothy A Benke, et al.
American Journal of Medical Genetics. Part A|June 14, 2025
Medical Biases and Misconceptions Impact Diagnoses in Males With Loss of Function MECP2 VariantsTalia Thompson, Dennis Gurfinkel, Lori Silveira, et al.
Epilepsia|December 9, 2022
Spike patterns surrounding sleep and seizures localize the seizure-onset zone in focal epilepsyErin C Conrad, Andrew Y Revell, Adam S Greenblatt, et al.
Journal of Neurodevelopmental Disorders|January 25, 2025
A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndromeKathleen Campbell, Jeffrey L Neul, David N Lieberman, et al.
Pageof 16